Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures - Trial NCT02368730
Access comprehensive clinical trial information for NCT02368730 through Pure Global AI's free database. This phase not specified trial is sponsored by Ferring Pharmaceuticals and is currently Completed. The study focuses on Platelet Dysfunction. Target enrollment is 23 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ferring Pharmaceuticals
Timeline & Enrollment
N/A
Jun 01, 2015
Jul 01, 2016
Primary Outcome
Change in platelet function pre- and post-administration of desmopressin
Summary
In this non-interventional multicentre, prospective, observational cohort study, the efficacy
 of desmopressin is evaluated in patients with platelet dysfunction due to acetylsalicylic
 acid or cox-1-inhibitors within the context of surgical procedures.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02368730
Non-Device Trial